.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Julphar
US Army
Harvard Business School
Cipla
Medtronic
Citi
Federal Trade Commission
McKinsey
Accenture

Generated: June 24, 2017

DrugPatentWatch Database Preview

FLAGYL I.V Drug Profile

« Back to Dashboard

Which patents cover Flagyl I.v, and when can generic versions of Flagyl I.v launch?

Flagyl I.v is a drug marketed by Pfizer and Baxter Hlthcare and is included in two NDAs.

The generic ingredient in FLAGYL I.V is metronidazole. There are eighteen drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

Summary for Tradename: FLAGYL I.V

Patents:0
Applicants:2
NDAs:2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLAGYL I.V at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
FLAGYL I.V.
metronidazole hydrochloride
INJECTABLE;INJECTION018353-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
FLAGYL I.V. RTU IN PLASTIC CONTAINER
metronidazole
INJECTABLE;INJECTION018353-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
FLAGYL I.V. RTU IN PLASTIC CONTAINER
metronidazole
INJECTABLE;INJECTION018657-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Medtronic
AstraZeneca
Teva
Moodys
Fuji
Healthtrust
Julphar
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot